TRIIM Growth Hormone Safety Metrics  Dr Greg Fahy Episode 3 episode artwork

EPISODE · Jan 9, 2022 · 12 MIN

TRIIM Growth Hormone Safety Metrics Dr Greg Fahy Episode 3

from Modern Healthspan · host Modern Healthspan

In this video Dr. Fahy discusses growth hormone and it benefits in aging. He also covers the safety checks that they performed after the participants started with the protocol. In particular they saw reduced markers of cancer and cancer risk Dr. Greg Fahy is a world renowned cryobiologist and is also the chief science officer, and co-founder, of Intervene Immune, a company which pioneers treatments for thymus regeneration and age-related immune system decline. Dr. Fahy Designed and led the pilot TRIIM trial which first time showing both thymus rejuvenation and reversal of human epigenetic age. He is now running the follow up phase II trial TRIIM-X with the aim of confirming and extending the results. If you would like to support our channel, we’d love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan

Episode metadata supplied by the publisher feed · Published Jan 9, 2022

Embed this episode

NOW PLAYING

TRIIM Growth Hormone Safety Metrics Dr Greg Fahy Episode 3

0:00 12:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Modern Healthspan?

This episode is 12 minutes long.

When was this Modern Healthspan episode published?

This episode was published on January 9, 2022.

Can I download this Modern Healthspan episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!